Oragenics Inc SEC filings OGEN

Oragenics Inc has 1,003 filings in SEC EDGAR's recent list, going back to Jun 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Oragenics Inc SEC filings
Form Description Filed Period
10-K Annual report Mar 16, 2026 Dec 31, 2025
10-K Annual report Mar 14, 2025 Dec 31, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
10-K Annual report Apr 17, 2023 Dec 31, 2022
10-K/A Amended annual report Jul 29, 2022 Dec 31, 2021
10-K Annual report Mar 24, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
10-K Annual report Mar 4, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 29, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2019 Dec 31, 2018
10-K Annual report Feb 16, 2018 Dec 31, 2017
10-K Annual report Feb 27, 2017 Dec 31, 2016
10-K/A Amended annual report Apr 27, 2016 Dec 31, 2015
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 27, 2015 Dec 31, 2014
10-K Annual report Feb 27, 2015 Dec 31, 2014
10-K Annual report Feb 28, 2014 Dec 31, 2013
10-K Annual report Mar 26, 2013 Dec 31, 2012
10-K Annual report Apr 16, 2012 Dec 31, 2011
10-K Annual report Mar 30, 2011 Dec 31, 2010
10-K/A Amended annual report Apr 28, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2010 Dec 31, 2009
ARS Annual report to shareholders Oct 1, 2009 Dec 31, 2008
10-K/A Amended annual report Jul 24, 2009 Dec 31, 2008
10-K/A Amended annual report Apr 29, 2009 Dec 31, 2008
10-K Annual report Apr 1, 2009 Dec 31, 2008

Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OGEN (NYSE)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Lakewood Ranch, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1174940

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.